Increased prostaglandin E2 release and activated Akt/β-catenin signaling pathway occur after opioid withdrawal in rat spinal cord

Anesthesiology

Volumn 105, Issue 1, 2006, Pages 154-159

  Dunbar, Stuart A ^a   Karamian, Ivan ^a   Roberts, Lou ^a   Zhang, Jiahui ^a  

^a BAYSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CYCLOOXYGENASE 2; MORPHINE; OPIATE; PROSTAGLANDIN E2; PROTEIN KINASE; PROTEIN KINASE B; SERINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DRUG WITHDRAWAL; ENZYME PHOSPHORYLATION; HYPERALGESIA; MALE; MICRODIALYSIS; NERVE CELL; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; SPINAL CORD; STATISTICAL SIGNIFICANCE; UPREGULATION; ANIMAL; COMPARATIVE STUDY; DRUG EFFECT; METABOLISM; MORPHINE ADDICTION; PHYSIOLOGY; SECRETION; SPRAGUE DAWLEY RAT; WITHDRAWAL SYNDROME;

ANIMALS; BETA CATENIN; DINOPROSTONE; MALE; MORPHINE; MORPHINE DEPENDENCE; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; SPINAL CORD; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 33746902012     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/00000542-200607000-00025     Document Type: Article

References (37)

1. Bailey CP, Connor M: Opioids: Cellular mechanisms of tolerance and physical dependence. Curr Opin Pharmacol 2005; 5:60-8
2. Ossipov MH, Lai J, King T, Vanderah TW, Porreca F: Underlying mechanisms of pronociceptive consequences of prolonged morphine exposure. Biopolymers 2005; 80:319-24
3. Dunbar SA, Pulai IJ: Repetitive opioid abstinence causes progressive hyperalgesia sensitive to N-methyl-D-aspartate receptor blockade in the rat. J Pharmacol Exp Ther 1998; 284:678-86
4. Dunbar SA, Karamov IG, Buerkle H: The effect of spinal ibuprofen on opioid withdrawal in the rat. Anesth Analg 2000; 91:417-22
5. Reznikov I, Pud D, Eisenberg E: Oral opioid administration and hyperalgesia in patients with cancer or chronic nonmalignant pain. Br J Clin Pharmacol 2005; 60:311-8
6. Dunbar SA, Yaksh TL: Concurrent spinal infusion of MK801 blocks spinal tolerance and dependence induced by chronic intrathecal morphine in the rat. ANESTHESIOLOGY 1996; 84:1177-88
7. Kiefer W, Dannhardt G: COX-2 inhibition and the control of pain. Curr Opin Investig Drugs 2002; 3:1348-58
8. Murakami M, Nakatani Y, Tanioka T, Kudo I: Prostaglandin E synthase. Prostaglandins Other Lipid Mediat 2002; 68-69:383-99
9. Svensson CI, Yaksh TL: The spinal phospholipase-cyclooxygenase-prostanoid cascade in nociceptive processing. Annu Rev Pharmacol Toxicol 2002; 42:553-83
10. Song G, Ouyang G, Bao S: The activation of Akt/PKB signaling pathway and cell survival. J Cell Mol Med 2005; 9:59-71
11. Tegeder I, Geisslinger G: Opioids as modulators of cell death and survival: Unraveling mechanisms and revealing new indications. Pharmacol Rev 2004; 56:351-69
12. Tan M, Groszer M, Tan AM, Pandya A, Liu X, Xie CW: Phosphoinositide 3-kinase cascade facilitates mu-opioid desensitization in sensory neurons by altering G-protein-effector interactions. J Neurosci 2003; 23:10292-301
13. Iglesias M, Segura MF, Comella JX, Olmos G: Mu-opioid receptor activation prevents apoptosis following serum withdrawal in differentiated SH-SY5Y cells and cortical neurons via phosphatidylinositol 3-kinase. Neuropharmacology 2003; 44:482-92
14. Polakiewicz RD, Schieferl SM, Gingras AC, Sonenberg N, Comb MJ: μ-Opioid receptor activates signaling pathways implicated in cell survival and translational control. J Biol Chem 1998; 273:23534-41
15. Muller DL, Unterwald EM: In vivo regulation of extracellular signal-regulated protein kinase (ERK) and protein kinase B (Akt) phosphorylation by acute and chronic morphine. J Pharmacol Exp Ther 2004; 310:774-82
16. Dunbar SA, Karamian IG: Periodic abstinence enhances nociception without significantly altering the antinociceptive efficacy of spinal morphine in the rat. Neurosci Lett 2003; 344:145-8
17. Marsala M, Malmberg AB, Yaksh TL: The spinal loop dialysis catheter: characterization of use in the unanesthetized rat. J Neurosci Methods 1995; 62:43-53
18. Yoburn BC, Chen J, Huang T, Inturrisi CE: Pharmacokinetics and pharmacodynamics of subcutaneous morphine pellets in the rat. J Pharmacol Exp Ther 1985; 235:282-6
19. Geisslinger G, Muth-Selbach U, Coste O, Vetter G, Schrodter A, Schaible HG, Brune K, Tegeder I: Inhibition of noxious stimulus-induced spinal prostaglandin E2 release by flurbiprofen enantiomers: A microdialysis study. J Neurochem 2000; 74:2094-100
20. Tegeder I, Niederberger E, Vetter G, Brautigam L, Geisslinger G: Effects of selective COX-1 and -2 inhibition on formalin-evoked nociceptive behaviour and prostaglandin E(2) release in the spinal cord. J Neurochem 2001; 79:777-86
21. Ibuki T, Marsala M, Masuyama T, Yaksh TL: Spinal amino acid release and repeated withdrawal in spinal morphine tolerant rats. Br J Pharmacol 2003; 138:689-97
22. Trang T, Sutak M, Quirion R, Jhamandas K: The role of spinal neuropeptides and prostaglandins in opioid physical dependence. Br J Pharmacol 2002; 136:37-48
23. Powell KJ, Hosokawa A, Bell A, Sutak M, Milne B, Quirion R, Jhamandas K: Comparative effects of cyclo-oxygenase and nitric oxide synthase inhibition on the development and reversal of spinal opioid tolerance. Br J Pharmacol 1999; 127:631-44
24. Wong CS, Hsu MM, Chou R, Chou YY, Tung CS: Intrathecal cyclooxygenase inhibitor administration attenuates morphine antinociceptive tolerance in rats. Br J Anaesth 2000; 85:747-51
25. Vazquez-Prado J, Casas-Gonzalez P, Garcia-Sainz JA: G protein-coupled receptor cross-talk: Pivotal roles of protein phosphorylation and protein-protein interactions. Cell Signal 2003; 15:549-57
26. Behrens J: Control of beta-catenin signaling in tumor development. Ann N Y Acad Sci 2000; 910:21-33
27. Ozawa M, Ringwald M, Kemler R: Uvomorulin-catenin complex formation is regulated by a specific domain in the cytoplasmic region of the cell adhesion molecule. Proc Natl Acad Sci U S A 1990; 87:4246-50
28. Murase S, Mosser E, Schuman EM: Depolarization drives beta-Catenin into neuronal spines promoting changes in synaptic structure and function. Neuron 2002; 35:91-105
29. Mayer DJ, Mao J, Holt J, Price DD: Cellular mechanisms of neuropathic pain, morphine tolerance, and their interactions. Proc Natl Acad Sci U S A 1999; 96:7731-6
30. Petrenko AB, Yamakura T, Baba H, Shimoji K: The role of N-methyl-Daspartate (NMDA) receptors in pain: A review. Anesth Analg 2003; 97:1108-16
31. Bozdagi O, Shan W, Tanaka H, Benson DL, Huntley GW: Increasing numbers of synaptic puncta during late-phase LTP: N-cadherin is synthesized, recruited to synaptic sites, and required for potentiation. Neuron 2000; 28:245-59
32. Tang L, Hung CP, Schuman EM: A role for the cadherin family of cell adhesion molecules in hippocampal long-term potentiation. Neuron 1998; 20:1165-75
33. Dunbar SA, Yaksh TL: Spinal infusion of N-methyl-D-aspartate antagonist MK801 induces hypersensitivity to the spinal alpha-2 agonist ST91 in the rat. J Pharmacol Exp Ther 1997; 281:1219-25
34. David C, Davis N, Mason R, Wilson VG: Evidence for functional dissociation of dependence and tolerance in guinea-pig isolated ileal segments following 20 hour exposure to morphine in vitro. Br J Pharmacol 1993; 110:1522-6
35. Aley KO, Levine JD: Different mechanisms mediate development and expression of tolerance and dependence for peripheral mu-opioid antinociception in rat. J Neurosci 1997; 17:8018-23
36. Mandyam CD, Thakker DR, Standifer KM: Micro-opioid-induced desensitization of opioid receptor-like 1 and micro-opioid receptors: Differential intracellular signaling determines receptor sensitivity. J Pharmacol Exp Ther 2003; 306:965-72
37. Terman GW, Jin W, Cheong YP, Lowe J, Caron MG, Lefkowitz RJ, Chavkin C: G-protein receptor kinase 3 (GRK3) influences opioid analgesic tolerance but not opioid withdrawal. Br J Pharmacol 2004; 141:55-64